Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Petra Jilma"'
Autor:
Katarina D. Kovacevic, Jürgen Grafeneder, Christian Schörgenhofer, Georg Gelbenegger, Gloria Gager, Christa Firbas, Peter Quehenberger, Petra Jilma-Stohlawetz, Andrea Bileck, Shuhao Zhu, James C. Gilbert, Martin Beliveau, Bernd Jilma, Ulla Derhaschnig
Publikováno v:
Haematologica, Vol 107, Iss 9 (2021)
Von Willebrand factor (VWF) and factor VIII (FVIII) circulate in a noncovalent complex in blood and promote primary hemostasis and clotting, respectively. A new VWF A1-domain binding aptamer, BT200, demonstrated good subcutaneous bioavailability and
Externí odkaz:
https://doaj.org/article/e56807657eb34193873de3efd70e7f5d
Autor:
Cihan Ay, Katarina D. Kovacevic, Daniel Kraemmer, Christian Schoergenhofer, Georg Gelbenegger, Christa Firbas, Peter Quehenberger, Petra Jilma-Stohlawetz, James C. Gilbert, Shuhao Zhu, Martin Beliveau, Franz Koenig, Alfonso Iorio, Bernd Jilma, Ulla Derhaschnig, Ingrid Pabinger
Publikováno v:
Blood. 141:1147-1158
Factor VIII (FVIII) circulates in a noncovalent complex with von Willebrand Factor (VWF), the latter determining FVIII half-life. The VWF-binding aptamer rondaptivon pegol (BT200) increases plasma levels of VWF/FVIII in healthy volunteers. This trial
Autor:
Cihan Ay, Ingrid Pabinger, Katarina D. Kovacevic, Georg Gelbenegger, Christian Schörgenhofer, Peter Quehenberger, Petra Jilma-Stohlawetz, Raute Sunder-Plassman, James C. Gilbert, Shuhao Zhu, Bernd Jilma, Ulla Derhaschnig
Publikováno v:
Blood Advances. 6:5467-5476
Type 2B von Willebrand disease (VWD) is characterized by an increased binding affinity of von Willebrand factor (VWF) to platelet glycoprotein Ib. This can lead to clearance of high-molecular-weight (HMW) multimers and thrombocytopenia with a resulti
Autor:
Bernd Jilma, Gloria M. Gager, Georg Gelbenegger, Andrea Bileck, Christa Firbas, Peter Quehenberger, Ulla Derhaschnig, Petra Jilma-Stohlawetz, Jürgen Grafeneder, Katarina D. Kovacevic, Shuhao Zhu, James C. Gilbert, Christian Schörgenhofer, Martin Beliveau
Publikováno v:
Haematologica. 107:2121-2132
Von Willebrand factor (VWF) and factor VIII (FVIII) circulate in a noncovalent complex in blood and promote primary hemostasis and clotting, respectively. A new VWF A1-domain binding aptamer, BT200, demonstrated good subcutaneous bioavailability and
Autor:
Raphael Preiss, Johannes Thaler, Petra Jilma, Ingrid Pabinger, Eva Mikušková, Peter Quehenberger, Stephan Kudrnovsky-Moser, Florian Roitner, Joachim Rettl, Nazanin Samadi, Paul Knoebl, Cihan Ay
Publikováno v:
Thrombosis Research. 207:126-130
BACKGROUND: Cases of ChAdOx1 nCoV-19 (AstraZeneca) vaccinated patients with thrombocytopenia, elevated D-dimer, and elevated platelet factor 4 (PF4) antibody levels with- and without thrombosis have been reported. No recommendations regarding the dur
Autor:
Anna E. Lowe, Robert Jones, Steve Kitchen, Ulrich Geisen, Gergely Rozsnyai, Petra Jilma, Peter Quehenberger
Publikováno v:
Journal of Clinical Laboratory Analysis. 36
We conducted a multicenter evaluation of a new one-stage factor VIII (FVIII) assay (Roche Diagnostics), intended for the quantitative assessment of FVIII activity. We evaluated the analytical performance of the FVIII assay on the cobas t 711 analyzer
Endotoxin Down-Modulates Granulocyte Colony-Stimulating Factor Receptor (CD114) on Human Neutrophils
Autor:
Hollenstein, Ursula, Homoncik, Monika, Stohlawetz, Petra Jilma, Marsik, Claudia, Sieder, Anna, Eichler, Hans-Georg, Jilma, Bernd
Publikováno v:
The Journal of Infectious Diseases, 2000 Jul 01. 182(1), 343-346.
Externí odkaz:
https://www.jstor.org/stable/30110055
Autor:
Anna Schoeberl, Petra Jilma, Sophie Neumayer, Stijn Van Malderen, Andreas Peyrl, Sarah Theiner, Gunda Koellensperger, Andreas Schweikert
Publikováno v:
Analytical Chemistry. 91:8207-8212
In this work, a combination of routine clinical practice and state-of-the-art laser ablation-inductively coupled plasma time-of-flight mass spectrometry (LA-ICP-TOFMS) imaging is presented for multielement analysis of single cells on clinical samples
Autor:
Petra Jilma-Stohlawetz, Peter Quehenberger, Katharina Lysy, Bernd Jilma, Raute Sunder-Plassmann, Sabine Belik, Ingrid Pabinger
Publikováno v:
International journal of laboratory hematologyREFERENCES. 43(2)
Introduction The aim of this study was to evaluate the Hemoclot Quanti. V-L assay in various clinical conditions. Methods We compared the Hemoclot Quanti.V-L assay with DNA testing and with the Pefakit assay in 60 normal (no mutation) vs carriers of
Autor:
Christian Schoergenhofer, Bernd Jilma, Barbara Thaler, Georg Gelbenegger, Gernot Schabbauer, Marion Mussbacher, Petra Jilma-Stohlawetz, Nina Buchtele, Johann Wojta, Michael Schwameis
Publikováno v:
Thrombosis and Haemostasis. 118:1176-1184
The protease-activated receptor-1 (PAR-1) is critically involved in the co-activation of coagulation and inflammatory responses. Vorapaxar is a reversible, orally active, low molecular weight, competitive antagonist of PAR-1.We investigated the effec